The PhD Course in Immunology, Molecular Medicine and Applied Biotechnology (IMMAB) is an innovative interfaculty initiative of Tor Vergata University in Rome finalized to provide cutting edge scientific skills in translational medicine. The IMMAB Course aims at achieving the educational target of developing graduated scientists able to conjugate basic and applied science. After completing their IMMAB doctoral education, students are to have developed an advanced general knowledge of medical science and scientific methodology in whatever research field they choose to explore for their final thesis.
The main objectives of the IMMAB PhD Course are:
- To develop a cultural and experimental bridge between basic and applied research.
- To provide new scientists with a broad grounding in the subject and to prepare them for their scientific and professional futures beyond the scope of the study plan for an individual project.
- To facilitate the career opportunities in the fields of medicine, health science, and biomedical research.
The content of the doctoral studies is outlined in the individual study plan written by the doctoral student and supervisor together and approved by the head of the department. The individual study plan describes how the goals of the education will be achieved and consists of a research plan, a financing plan, description of the supervision and a list of courses and other activities.
The main educational goals are:
1. The achievement of scientific independence and leadership capacity.
2. The achievement of cutting edge methodological skills in both laboratory and clinical research.
3. The achievement of high quality knowledge in molecular biology and biomedicine.
The educational goals will take advantage from the active participation of PhD students in scientific seminars in both Faculty of Medicine and Faculty of Natural and Mathematical Sciences, in Tor Vergata University.
The PhD student will be specifically trained in immunology and immunopathology in order to be able to develop innovative research projects in the fields of laboratory immune tests, immune therapies of allergic and autoimmune diseases, antineoplastic immune therapies, monitoring tools of therapeutic efficacy and immune response modulation.
The PhD course will include training periods in world-renowned centers such as:
· “Bambino Gesù” Children’s Hospital, Rome, Italy
· San Raffaele Hospital, Milan, Italy
· Karolinska Institute, Stockholm, Sweden
· Necker Hospital, Paris, France